3-furanyl analogs of toxoflavine as kinase inhibitors

Details 3-furanyl analogs of toxoflavine as kinase inhibitors 3-furanyl analogs of toxoflavine as kinase inhibitors

2007-07-10

2007-07-10

Balasubramanian, Venkataraman (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C544S184000

Reexamination Certificate

active

10520641

ABSTRACT:
The present invention concerns the compounds of formulathe N-oxide forms, the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, wherein m, n, R1, R2, R3, R4and R5are as defined herein, the use of such compounds as inhibitors of cyclin-dependent serine/threonine kinases (Cdks), as well as kinases and phosphatases involved in cell cycle regulation such as the tyrosine kinases Wee1, Mik1 and Myt1 or the tyrosine dephosphatases such as Cdc25 and Pyp3. The present invention is further directed to pharmaceutical compositions comprising the compounds of the present invention and to methods for treating cell proliferative disorders such as atherosclerosis, restenosis and cancer.

REFERENCES:
patent: 4568649 (1986-02-01), Bertoglio-Matte
patent: 2039883 (1980-08-01), None
patent: 09-255681 (1997-09-01), None
patent: WO 02/02552 (2002-01-01), None
patent: WO 02/20525 (2002-03-01), None
patent: WO 02/20525 (2002-03-01), None
Meijer L., et al., “Chemical Inhibitors of Cyclin-Dependent Kinases”, Progress in Cell Cycle Research, vol. 1, 351-363, 1995.
Kaur, et al., “Growth Inhibition With Reversible Cell Cycle Arrest of Carcinoma Cells by Flavone L86-8275”, J. Natl. Cancer Inst., vol. 84(22), 1736-1740, 1992.
Sedlacek, et al., “Flavopiridol (L86 8275; NSC 649890), a new kinase inhibitor for tumor therapy”, Int. J. Oncol, vol. 9:1143-1168, 1996.
Vesely, et al., “Inhibition of cyclin-dependent kinases by purine analogues”, Eur. J. Biochem, 224, 771-786, 1994.
Gennaro, et al., “Remington's Pharmaceutical Sciences”, 18thedition, Mack Publishing Company, 1990 book cover & table of contents.
Nagamatsu, et al., “General syntheses of 1-alkyltoxoflavin and 8-alkylfervenulin derivatives of biological significance by the regioselective alkylation of reumycin derivatives and the rates of transalkylation from 1-alkyltoxoflavins into nucleophiles”, J. Chem. Soc., Perkin Trans. 1, 130-137, 2001.
Nagamatsu, et al., “Syntheses of 3-Substituted 1-Methyl-6-phenylpyrimido[5,4-e]-1,2,4-triazine-5,7(1H,6H)-diones (6-Phenyl Analogs of Toxoflavin) and Their 4-Oxides, and Evaluation of Antimicrobial Activity of Toxoflavins and Their Analogs”,, Chem. Pharm. Bull 41(2) 362-368, 1993.
Wiley & Sons, Inc., “Fused Pyrimidines Miscellaneous Fused Pyrimidines”, Heterocyclic Compounds, vol. 24 (part 4) p. 261-304.
International Search Report mailed Oct. 23, 2003 for PCT/EP03/50293.

Affiliated with

Also associated with

Rating

3-furanyl analogs of toxoflavine as kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 3-furanyl analogs of toxoflavine as kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-furanyl analogs of toxoflavine as kinase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3773141